Emerge Commerce ($ECOM.V) FINS Review
Emerge Commerce's $44 million COVID-era acquisitions produced losses and impairments, while modestly improved Q2 liquidity leaves its balance sheet and capital needs under scrutiny.
Emerge Commerce's $44 million COVID-era acquisitions produced losses and impairments, while modestly improved Q2 liquidity leaves its balance sheet and capital needs under scrutiny.
@ryanTesling @elliotrades worry isn’t something i do often. a rate hike is a known risk investors won’t like short term, but it changes nothing about my larger $AMZN thesis.
@davey_juice @ThainRos $EWZ might go lower. I don't have a strong opinion on where big components like Vale and Petrobras go, could be down more. I think $INTR and $NU will keep growing fast enough to offset macro jitters.
@elliotrades $AMZN
Nubank and Inter face Brazilian election risk as Lula is expected to win despite stronger polling for Flavio.
@davey_juice @ThainRos I remember someone wanting to bet me that Nigeria would outperform Colombia over the long term. $COLO now +150% past three years while the Nigeria ETF got delisted, so yeah, about that.
Rayonier, $RYN, carries a $7.4 billion enterprise value and four million acres, implying $1,817 per acre plus a dividend.
@Freedom2Fart not a swing trader. and not that it matters, but the $AMZN trade in question was a one day options trade into expiration. fully exited.
Horizon Technology Finance, $LIEN, trades at $10.20 versus $13.26 NAV and yields 13.3% as its all-stock REFI deal nearly doubles assets to about $800 million.
Veeva beat its $905 million revenue guide with $928 million, up 17.6%, while subscription growth accelerated and GAAP EBIT margin reached…
Microsoft’s AI data-center buildout lifted annual CapEx from $5.5 billion in FY2014 to $115.9 billion in FY2026, resetting free-cash-flow…
NTG Clarity’s $18.6M of Q2 service revenue sat in contract assets, while $4.6M cash burn cut cash to $2.85M and raises liquidity concerns.
Meta’s $18 billion teen-addiction settlement makes $5.3 billion contingent on YouTube and TikTok adopting matching restrictions, while…
Sandisk’s FY28-FY30 model relies on long-term NAND agreements holding near-80% gross-margin floors despite pricing 26-28% below current…
Higher rates could compress equity multiples and raise AI data center lease costs, while UWMC and Cogent raise questions about CEO-driven…
Verra Mobility renewed Hertz tolling management for five years. AutoKinex lets rental customers buy tolling, fuel and protection products…
Nvidia guided FY2028 revenue toward $700 billion, roughly 70% growth, while supply constraints and neocloud demand face concerns over…
Domo’s $400 million sale to Progress would leave a cash-rich public shell with $900 million of NOLs; January 2028 $5 calls cost 22 cents.
Net Lease Office Properties is a REIT office basket pursuing a spin-off and liquidation.
GCI Liberty trades cheaply, holds tax assets, and faces investor fatigue with John Malone.
NSTS Bancorp’s three-year thrift-conversion anniversary could clear the way for a potential sale.
Kronos Bio’s Tang buyout includes a contingent value right with unusual consideration terms.
Repare Therapeutics faces a broken biotech valuation and potential strategic alternatives.
Mural Oncology is a former spin-off biotech now described as broken.
Elevation Oncology is a broken biotech with a slightly riskier setup.
Dun & Bradstreet’s strategic process is wrapping up as the company trades at a cheap valuation.
Third Harmonic Bio is pursuing strategic alternatives while preserving options for its THB335 program.
An aerospace company’s profitable core is obscured by a long-running FAA development program; approval, abandonment, or shrinking losses…
Stories are added via a curated list of writers we follow. Have a source we're missing?
Send your pickEvery publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.